Results 1 to 10 of about 35,933 (220)

δ-Aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines [PDF]

open access: yesBMC Cancer, 2002
Background Acute Intermittent Porphyria is a genetic disorder of heme metabolism, characterized by increased levels of porphyrin precursors, δ-aminolevulinic acid (ALA) and porphobilinogen (PBG).
del Batlle Alcira M   +4 more
doaj   +6 more sources

Cathepsin B-Responsive Liposomes for Controlled Anticancer Drug Delivery in Hep G2 Cells [PDF]

open access: yesPharmaceutics, 2020
In recent decades, several types of anticancer drugs that inhibit cancer cell growth and cause cell death have been developed for chemotherapeutic application.
Seulgi Lee   +4 more
doaj   +2 more sources

Peran Asam Klorogenat Terhadap Ekspresi Gen; miRNA 146 A, Caspase 3, Cyclin D1, dan Kematian Sel Kanker Hepatoseluler Model Cell Lines Hep-G2 [PDF]

open access: yesIndonesian Journal of Cancer, 2014
Chlorogenic acid (CA) is the active compound isolated from medicinal plants, can be used as a chemopreventive agents of hepatocellular cancer (HCC). It works as an exogenous antioxidant and inhibit growth of cancer cells through the inhibition of free ...
ASEP SUKOHAR   +5 more
doaj   +2 more sources

Frankincense oil nanoemulsion induces selective cytotoxicity and over ROS-mediated oxidative stress and apoptotic DNA damage in Hep-G2 hepatic cancer cells [PDF]

open access: yesScientific Reports
Frankincense oil nanoemulsion (FONE) exhibits high bioavailability, enhanced cellular uptake, and improved kinetic stability, making it a promising candidate for therapeutic applications.
Hanan R. H. Mohamed   +2 more
doaj   +2 more sources

Physiological characteristics and green production NiO nanoparticle synthesis employing Moringa Oleifera lam extract to assess in vitro cytotoxicity, antibacterial [PDF]

open access: yesScientific Reports
Moringa Oleifera is a medicinal plant that is used in the production of cytotoxic agents, which are used in cancer treatment to prevent the division and spread of cancer cells.
Abdulhassan Mahdi Salih   +3 more
doaj   +2 more sources

Toxicity study of Gloydius brevicaudus venom on Hela and Hep G2 cells [PDF]

open access: yesBIO Web of Conferences, 2023
The purpose of this study was to explore the cytotoxicity of Gloydius brevicauda venom on tumor cells. Hela and Hep G2 cells were used as the research subjects.
Hu Jianguo   +2 more
doaj   +1 more source

Cytotoxicity and Apoptosis Induction of 6,7-Dehydroroyleanone from Taiwania cryptomerioides Bark Essential Oil in Hepatocellular Carcinoma Cells

open access: yesPharmaceutics, 2022
The objective of the present study is to evaluate the cytotoxicity of Taiwania cryptomerioides essential oil and its phytochemical on the Hep G2 cell line (human hepatocellular carcinoma).
Guan-Rong Chen   +4 more
doaj   +1 more source

Induction of ROS mediated genomic instability, apoptosis and G0/G1 cell cycle arrest by erbium oxide nanoparticles in human hepatic Hep-G2 cancer cells

open access: yesScientific Reports, 2022
The remarkable physical and chemical characteristics of noble metal nanoparticles, such as high surface-to-volume ratio, broad optical properties, ease of assembly, surfactant and functional chemistry, have increased scientific interest in using erbium ...
Gehan Safwat   +2 more
doaj   +1 more source

Bi-module sensing device to in situ quantitatively detect hydrogen peroxide released from migrating tumor cells. [PDF]

open access: yesPLoS ONE, 2015
Cell migration is one of the key cell functions in physiological and pathological processes, especially in tumor metastasis. However, it is not feasible to monitor the important biochemical molecules produced during cell migrations in situ by ...
Ling Yu   +5 more
doaj   +1 more source

Transferrin-conjugated liposomes loaded with novel dihydroquinoline derivatives as potential anticancer agents. [PDF]

open access: yesPLoS ONE, 2017
A series of 1,2-dihydroquinoline derivatives were synthesized and evaluated for cytotoxicity in HeLa, Hep G2 and 6HEK-293T cell lines. EEDQ2 was identified as a promising anti-cancer agent with low IC50 in HeLa (18.55μg/ml) and Hep G2 (14.53μg/ml) cells.
Mengqiao Wang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy